Tag: Drug Companies

The champion of painkillers

The champion of painkillers

The annual death toll from overdoses of painkillers has reached almost 15,000, prompting the head of the CDC to term it an “epidemic.” But the American Pain Foundation continues to claim the risks are overblown. The advocacy group’s biggest supporter? The drug industry.

Share
December 24, 2011 | 0 Comments More
Photo: Hanspeter Klasser

How doctors die, Newt’s health care heresies and other top stories of the week

How doctors die (Hint: Not like the rest of us). Can vaccines end cancer? Newt Gingrich’s health-care heresies. Should your doctor take money from drug companies? — This week’s top stories.

Share
December 18, 2011 | 0 Comments More
Doctors avoid penalties in suits against medical firms

Doctors avoid penalties in suits against medical firms

Drug and device companies have paid $6.5 billion since 2008 to settle accusations of illegal marketing practices, but none of the more than 75 doctors named as participants have been sanctioned,

Share
September 16, 2011 | 0 Comments More
Health advocacy groups take drug company cash—often without full disclosures, report

Health advocacy groups take drug company cash—often without full disclosures, report

Not-for-profit health advocacy groups that take money from drug companies in the form of grants—more often than not—aren’t disclosing that support.

Share
January 13, 2011 | 0 Comments More
Doctors on pharma payroll have blemished records, limited credentials

Doctors on pharma payroll have blemished records, limited credentials

Hundreds of doctors paid by drug companies to lecture about their drugs have been accused of misconduct, been disciplined by state boards or lack specialist or academic credentials.

Share
October 19, 2010 | 0 Comments More
Boehner Blasts PhRMA On Deal With White House

Boehner Blasts PhRMA On Deal With White House

Calls President A ‘Bully’ By Mary Agnes Carey – Kaiser Health News The drug industry’s decision to agree to $80 billion in concessions to the White House was short-sighted, will hurt drug manufacturers and their customers, and “has all the markings of a deal gone sour,” House Minority Leader John Boehner wrote Monday to his [...]

Share
August 17, 2009 | 0 Comments More
For Major Health Industry Players, Reform’s Positives Outweigh Negatives

For Major Health Industry Players, Reform’s Positives Outweigh Negatives

By Phil Galewitz August 11, 2009 When Congress and the White House began talking about a health care overhaul, the industries that profit from the $2.5 trillion system were understandably nervous. But as the legislation takes shape, it appears much of the anxiety was misplaced. Most of the major health care players, including hospitals, health [...]

Share
August 11, 2009 | 0 Comments More